2020
Integrating and Interpreting Findings from the Latest Treatment as Prevention Trials
Brault MA, Spiegelman D, Abdool Karim SS, Vermund SH. Integrating and Interpreting Findings from the Latest Treatment as Prevention Trials. Current HIV/AIDS Reports 2020, 17: 249-258. PMID: 32297219, PMCID: PMC7260110, DOI: 10.1007/s11904-020-00492-4.Peer-Reviewed Original Research
2018
Assessing Individual and Disseminated Effects in Network-Randomized Studies
Buchanan AL, Vermund SH, Friedman SR, Spiegelman D. Assessing Individual and Disseminated Effects in Network-Randomized Studies. American Journal Of Epidemiology 2018, 187: 2449-2459. PMID: 30052722, PMCID: PMC6211234, DOI: 10.1093/aje/kwy149.Peer-Reviewed Original Research
2007
The Future of HIV Prevention: Control of Sexually Transmitted Infections and Circumcision Interventions
Sahasrabuddhe VV, Vermund SH. The Future of HIV Prevention: Control of Sexually Transmitted Infections and Circumcision Interventions. Infectious Disease Clinics Of North America 2007, 21: 241-257. PMID: 17502238, PMCID: PMC2700301, DOI: 10.1016/j.idc.2007.03.005.Peer-Reviewed Original ResearchConceptsHIV infectionGenital tract inflammationMale circumcision programsSTI treatmentCircumcision programsSymptomatic personsHIV preventionCurrent evidenceMale circumcisionCircumcision interventionsInfectionHIVSeparate trialsPreventionTreatmentResearch prioritiesInflammationPersonsControlTrialsCircumcision
2006
Migration patterns following HIV diagnosis among adults residing in the nonurban Deep South
Agee BS, Funkhouser E, Roseman JM, Fawal H, Holmberg SD, Vermund SH. Migration patterns following HIV diagnosis among adults residing in the nonurban Deep South. AIDS Care 2006, 18: 51-58. PMID: 16938675, DOI: 10.1080/09540120600839355.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHIV diagnosisAIDS-defining conditionsMost HIV transmissionHIV specialty clinicsInjection drug usersHIV prevention programsHealth care needsHIV statusHIV transmissionImmunodeficiency virusCare needsDrug usersPrevention programsMost subjectsDiagnosisTransmission dynamicsInfectionDeep SouthClinicPersons
2001
Development and Characterization of a Molecular Viability Assay for Pneumocystis carinii f sp hominis
Maher N, Vermund S, Welsh D, Dillon H, Awooda A, Unnasch T. Development and Characterization of a Molecular Viability Assay for Pneumocystis carinii f sp hominis. The Journal Of Infectious Diseases 2001, 183: 1825-1827. PMID: 11372040, DOI: 10.1086/320738.Peer-Reviewed Original ResearchConceptsPneumocystis carinii pneumoniaHuman immunodeficiency virus-infected personsP. cariniiCommon opportunistic infectionVirus-infected personsCarinii pneumoniaOpportunistic infectionsPerson transmissionHuman P. cariniiClinical specimensTransmission dynamicsCariniiInfectionViability assaysMolecular viabilityImportance of personPneumoniaReliable methodEpidemiologyPersons
1999
HIV/AIDS in Nonurban Alabama: Risk Activities and Access to Services Among HIV-Infected Persons
BELTRAMI J, VERMUND S, FAWAL H, MOON T, VON BARGEN J, HOLMBERG S. HIV/AIDS in Nonurban Alabama: Risk Activities and Access to Services Among HIV-Infected Persons. Southern Medical Journal 1999, 92: 677-683. PMID: 10414476, DOI: 10.1097/00007611-199907000-00006.Peer-Reviewed Original Research
1997
Detection of Pneumocystis carinii DNA in air samples: likely environmental risk to susceptible persons
Bartlett MS, Vermund SH, Jacobs R, Durant PJ, Shaw MM, Smith JW, Tang X, Lu JJ, Li B, Jin S, Lee CH. Detection of Pneumocystis carinii DNA in air samples: likely environmental risk to susceptible persons. Journal Of Clinical Microbiology 1997, 35: 2511-2513. PMID: 9316898, PMCID: PMC230001, DOI: 10.1128/jcm.35.10.2511-2513.1997.Peer-Reviewed Original ResearchConceptsP. carinii DNAHospital roomCarinii DNAPatient's hospital roomPneumocystis carinii DNASusceptible personsControl homesPatient's homeInfectious organismsPatientsPneumocystis cariniiCariniiP. cariniiAirborne presenceSpecific environmental sourcesAir samplesPersonsEnvironmental sourcesHomeEnvironmental sampling